Development of bullous pemphigoid during nivolumab therapy William Damsky, MD, PhD, Lauren Kole, MD, Mary M. Tomayko, MD, PhD JAAD Case Reports Volume 2, Issue 6, Pages 442-444 (November 2016) DOI: 10.1016/j.jdcr.2016.05.009 Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Bullous pemphigoid. Representative clinical image from the right thigh. JAAD Case Reports 2016 2, 442-444DOI: (10.1016/j.jdcr.2016.05.009) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Bullous pemphigoid. Representative clinical image from the right hand. JAAD Case Reports 2016 2, 442-444DOI: (10.1016/j.jdcr.2016.05.009) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 3 Bullous pemphigoid. Hematoxylin-eosin–stained section with paired immunofluorescence for complement C3 (inset). JAAD Case Reports 2016 2, 442-444DOI: (10.1016/j.jdcr.2016.05.009) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions